Document is current
Any future updates will be listed below
-
Authors
Atkins, Johnique T.
George, Goldy C.
Hess, Kenneth
Marcelo-Lewis, Kathrina L.
Yuan, Ying
Borthakur, Gautam
Khozin, Sean
LoRusso, Patricia
Hong, David S.
- License Information
-
More Information
Article History
Received: 20 February 2020
Revised: 23 July 2020
Accepted: 6 August 2020
First Online: 1 September 2020
Ethics approval and consent to participate
: This study did not need formal ethics approval per national guidelines, as this was a meta-analysis. [References: U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research, Manual of Policies and Procedures, 5/18/2009; Sullivan GM, Editorial - IRB 101, Journal of Graduate Medical Education, 2011].
: Not required/applicable as this study was a meta-analysis [References: U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research, Manual of Policies and Procedures, 5/18/2009; Sullivan GM, Editorial - IRB 101, Journal of Graduate Medical Education, 2011].
: Data are available from D.S.H. with a reasonable request.
: Dr. LoRusso reports the following financial disclosures: Advisory Board Member - AbbVie (2018-2019), GenMab (2016-2019), Genentech (2016-2019), CytomX (2016-2019), Takeda (2017-2020), Cybrexa (2018-2019), Agenus (2018-2020), IQVIA (2019-2020), TRIGR (2019-2020), Pfizer (2019-2020), I-MAB (2019-2020), ImmunoMet (2018-2020), Black Diamond (2019-2020), Glaxo-Smith Kline (2019-2020), QED Therapeutics (2019-2020), AstraZeneca (2019-2020), EMD Serono (2019-2020), Shattuck (2019-2020), Astellas (2019-2020), Salarius (2019-2020), Silverback (2019-2020), MacroGenics (2019-2020), Kyowa Kirin Pharmaceutical Development (2020-2021), Kineta, Inc. (2020-2021), Zentalis Pharmaceuticals (2020-2021), Molecular Templates (2020-2021); Data Safety Monitoring Board – Agios (2016-2019), Halozyme (2016-2019); Data Safety Monitoring Committee - Five Prime (2017-2020), Tyme (2018-2020); imCORE Alliance - Roche-Genentech (2016-2019); SOTIO Consultant (2018-2019). Dr. Hong reports grants from Bayer, Lilly, Genentech, LOXO, Pfizer, Amgen, Mirati, Ignyta, Merck, Daichii-Sanko, Eisai, Adaptimmune, Abbvie, Astra-Zeneca, BMS, Genmab, Infinity, Kite, Kyowa, Medimmune, Molecular Template, Novartis, Takeda, personal fees from Mirna, LOXO, other from Bayer, Baxter, Guidepoint global, Oncoresponse, Janssen, Molecular Match, outside the submitted work. The other authors have declared no conflicts.
: Not applicable.
